WebSHAREHOLDER Enquiries [email protected] Media Enquiries … WebImugene Limited (IMU) Stock Price & News - Google Finance Home IMU • ASX Imugene Limited Follow Share $0.12 Mar 14, 3:07:39 PM GMT+11 · AUD · ASX · Disclaimer search Compare to Immutep...
Imugene Limited (IMU.AX) Stock Price, News, Quote & History
Webthe Constitution of Imugene Limited. 1. Number of Options to be Exercised Total payment required @ $0.054 per Option , , A$ , , . If the dollar amount paid results in a fraction of a share then the shares allotted will be rounded down. 2. Payment: You can pay either by BPAY or EFT Option A –BPAY Option B Electronic Funds Transfer (EFT) 3. WebApr 14, 2024 · IMU News Today Why did Imugene stock go up today? ASX:IMU Imugene - IMU News Today Compare Today's Range N/A 50-Day Range N/A 52-Week Range N/A Volume 12.70 million shs Average Volume N/A Market Capitalization N/A P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile Chart Competitors Insider Trades Headlines highlife cannabis hanmer
IMU Stock Price Imugene Ltd. Stock Quote (Australia: Sydney ...
WebIUGNF Complete Imugene Ltd. stock news by MarketWatch. View real-time stock prices … WebApr 12, 2024 · About Imugene (ASX:IMU) Stock Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. WebManagement Team — Imugene (ASX: IMU) Dr Nick Ede Chief Technology Officer Dr Ede has over 25 years’ peptide vaccine and drug development. He was formerly CEO of Adistem and CEO of Mimotopes. Prior to that he was VP Chemistry at Chiron (now Novartis), and has been a Research Fellow at the CRC for Vaccine Technology. highlife campers